We aimed to provide recommendations on the infusion duration of anthracycline chemotherapy agents in children with cancer. This study also serves as a practice example of the essential steps that need to be taken when using a previously published systematic review to develop a high-quality clinical pract...
Reintam Blaser, A;
Starkopf, J;
Alhazzani, W;
Berger, M. M;
Casaer, M. P;
Deane, A. M;
Fruhwald, S;
Hiesmayr, M;
Ichai, C;
Jakob, S. M;
Loudet, C. I;
Malbrain, M. L;
Montejo González, J. C;
Paugam-Burtz, C;
Poeze, M;
Preiser, J. C;
Singer, P;
van Zanten, A. R;
de Waele, J;
Wendon, J;
Wernerman, J;
Whitehouse, T;
Wilmer, A;
Oudemans-van Straaten, H. M.
PURPOSE: To provide evidence-based guidelines for early enteral nutrition (EEN) during critical illness. METHODS: We aimed to compare EEN vs. early parenteral nutrition (PN) and vs. delayed EN. We defined "early" EN as EN started within 48 h independent of type or amount. We listed, a priori, conditions ...
Carson, JL;
Guyatt, G;
Heddle, NM;
Grossman, BJ;
Cohn, CS;
Fung, MK;
Gernsheimer, T;
Holcomb, JB;
Kaplan, LJ;
Katz, LM;
Peterson, N;
Ramsey, G;
Rao, SV;
Roback, JD;
Shander, A;
Tobian, AA.
"IMPORTANCE:
More than 100 million units of blood are collected worldwide each year, yet the indication for red blood cell (RBC) transfusion and the optimal length of RBC storage prior to transfusion are uncertain.
OBJECTIVE:
To provide recommendations for the target hemoglobin level for RBC transfusion...
The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. The 2015 update of the KDOQI Clinical Practice Guideline for Hemodialysis Adequacy is intended to...
Zinzani, Pier Luigi;
Marchetti, Monia;
Billio, Atto;
Barosi, Giovanni;
Carella, Angelo Michele;
Lazzarino, Mario;
Martelli, Maurizio;
Rambaldi, Alessandro;
Rigacci, Luigi;
Tarella, Corrado;
Vitolo, Umberto;
Tura, Sante.
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...
Anticuerpos Monoclonales,
Anticuerpos,
Anticuerpos Monoclonales de Origen Murino/uso terapéutico,
Antineoplásicos,
Esquema de Medicación,
Trasplante de Células Madre Hematopoyéticas,
Linfoma Folicular/patología,
Linfoma/terapia,
Estadificación de Neoplasias,
Rituximab,
Factores de Tiempo
